Company · CIK 0001894562 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Prime Medicine, Inc. · PRME
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 AForm 4 → | Jun 8, 4:21 pm EDT | David P SchenkeinDirector | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:20 pm EDT | Jeffrey D MarrazzoDirector | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:19 pm EDT | Robert NelsenDirector, 10% Owner | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:18 pm EDT | Michael Aaron KellyDirector | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:17 pm EDT | Kaye I Foster-CheekDirector | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:14 pm EDT | Wendy ChungDirector | 75,000 | — | — | 75,000 | — | |
| Jun 5, 2026 AForm 4 → | Jun 8, 4:13 pm EDT | Thomas CahillDirector | 75,000 | — | — | 75,000 | — |